Publications by authors named "Isabel Cirera"

Claim this Profile
F
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements.
Gennaro D'Amico, Alexander Zipprich, Càndid Villanueva, Juan Antonio Sordà, Rosa Maria Morillas, Isabel Cirera

Hepatology· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MultiCOVID: a multi modal deep learning approach for COVID-19 diagnosis.
Max Hardy-Werbin, José Maria Maiques, Marcos Busto, Isabel Cirera, Alfons Aguirre

Sci Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Revisit after discharge from the emergency department in a cohort of patients with COVID-19 pneumonia and analysis based on the healthcare resource used for follow-up. RESALSEVID study].
Arantxa Albert, Pere Llorens, Alfons Aguirre, Francisco Javier Martín-Sánchez, Silvia Mínguez, Isabel Cirera

J Healthc Qual Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociodemographic characteristics, functional status, and health resource use of older patients treated in Spanish emergency departments: a description of the EDEN cohort.
Òscar Miró, Javier Jacob, Eric Jorge García-Lamberechts, Pascual Piñera Salmerón, Pere Llorens, Isabel Cirera

Emergencias· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH).
César Jiménez, Meritxell Ventura-Cots, Margarita Sala, Margalida Calafat, Montserrat Garcia-Retortillo, Isabel Cirera

Liver Int· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on Hospital Admissions and Healthcare Quality Indicators in Non-COVID Patients: A Retrospective Study of the First COVID-19 Year in a University Hospital in Spain.
Laia Domingo, Mercè Comas, Anna Jansana, Javier Louro, Helena Tizón-Marcos, Isabel Cirera

J Clin Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbon monoxide poisoning in hookah users.
August Supervía, Rocío De Paz Picornell, Francisca Córdoba, Patricia Gallardo, Oriol Pallàs, Isabel Cirera

Emergencias· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.
Margarita Posso, Mercè Comas, Marta Román, Laia Domingo, Javier Louro, Isabel Cirera

Arch Bronconeumol (Engl Ed)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.
Margarita Posso, Mercè Comas, Marta Román, Laia Domingo, Javier Louro, Isabel Cirera

Arch Bronconeumol (Engl Ed)· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery.
Enric Reverter, Isabel Cirera, Agustín Albillos, Wilma Debernardi-Venon, Juan G Abraldes

J Hepatol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in clinical features of two immigrant populations with tuberculosis.
August Supervía, Oriol Pallàs, Lucilla Piccari, Sabina Herrera Fernández, Marisol Domínguez Álvarez, Isabel Cirera

Arch Bronconeumol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study.
Cristina Ripoll, Joan Genescà, Isis K Araujo, Isabel Graupera, Salvador Augustin, Isabel Cirera

Hepatology· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.
José Antonio Carrión, Elena Gonzalez-Colominas, Montserrat García-Retortillo, Nuria Cañete, Isabel Cirera

J Hepatol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical course of decompensated alcoholic cirrhosis: a prospective study of 165 patients.
Marco Antonio Alvarez, Isabel Cirera, Ricard Solà, Ana Bargalló, Rosa Maria Morillas

J Clin Gastroenterol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites.
Silvia Montoliu, Belén Ballesté, Ramon Planas, Marco Antonio Alvarez, Mònica Rivera, Isabel Cirera

Clin Gastroenterol Hepatol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients.
Cristina Tural, Josep Antón Galeras, Ramon Planas, Susanna Coll, Guillem Sirera, Isabel Cirera

Antivir Ther· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis.
Pedro Zapater, Rubén Francés, José M González-Navajas, Maria A de la Hoz, Rocío Moreu, Isabel Cirera

Hepatology· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of patients hospitalized for management of cirrhotic ascites.
Ramon Planas, Silvia Montoliu, Belen Ballesté, Monica Rivera, Mireia Miquel, Isabel Cirera

Clin Gastroenterol Hepatol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.
Ricard Solà, Marco Antonio Alvarez, Belén Ballesté, Silvia Montoliu, Mònica Rivera, Isabel Cirera

Liver Int· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.
Mercé Brunet, Isabel Cirera, Jaume Martorell, Elena Vidal, Olga Millán

Transplantation· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[66-year-old woman presenting with asthenia and eosinophilia].
Isabel Cirera, Pedro Arguis, Rosa Miquel

Med Clin (Barc)· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model.
Raúl Tonda, Ana María Galán, Marcos Pino, Isabel Cirera, Jaume Bosch

J Hepatol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression: predictive factors of response to antirejection therapy.
Hernán Andreu, Antoni Rimola, Miquel Bruguera, Miquel Navasa, Isabel Cirera

Transplantation· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis